Procarbazine (Natulan) in the treatment of Peyronie's disease. 1978

R J Morgan, and J P Pryor

Thirty-four men with Peyronie's diseases were treated with a 12-week course of the drug procarbazine (Natulan), preceded or followed by a 12-week course of vitamin E. Ninety-one per cent of the men failed to improve or became worse whilst receiving Natulan and toxic side-effects were common. In comparison 39% improved whilst taking vitamin E. We concluded that Natulan is of little benefit in the treatment of this condition and may indeed be harmful.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010411 Penile Induration A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both. Cavernitis, Fibrous,Peyronie's Disease,Penile Fibromatosis,Peyronie Disease,Plastic Induration of the Penis,Cavernitides, Fibrous,Fibromatosis, Penile,Fibrous Cavernitides,Fibrous Cavernitis,Peyronies Disease
D011344 Procarbazine An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease. Matulane,Natulan,Procarbazine Hydrochloride,Procarbazine Monohydrobromide,Procarbazine Monohydrochloride,Hydrochloride, Procarbazine,Monohydrobromide, Procarbazine,Monohydrochloride, Procarbazine
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014810 Vitamin E A generic descriptor for all TOCOPHEROLS and TOCOTRIENOLS that exhibit ALPHA-TOCOPHEROL activity. By virtue of the phenolic hydrogen on the 2H-1-benzopyran-6-ol nucleus, these compounds exhibit varying degree of antioxidant activity, depending on the site and number of methyl groups and the type of ISOPRENOIDS.

Related Publications

R J Morgan, and J P Pryor
April 1975, British journal of urology,
R J Morgan, and J P Pryor
July 1968, Bruxelles medical,
R J Morgan, and J P Pryor
December 1966, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde,
R J Morgan, and J P Pryor
January 1968, Annales medicinae internae Fenniae,
R J Morgan, and J P Pryor
January 1976, Scandinavian journal of urology and nephrology,
R J Morgan, and J P Pryor
March 1967, Experientia,
R J Morgan, and J P Pryor
January 1971, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
R J Morgan, and J P Pryor
December 1965, British medical journal,
R J Morgan, and J P Pryor
January 1971, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Copied contents to your clipboard!